BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 507990)

  • 1. Cardiovascular and autonomic actions of ciclazindol and tricyclic antidepressants.
    Waterfall JF; Smith MA; Gaston WH; Maher J; Warburton G
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):116-36. PubMed ID: 507990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cardiovascular effects of amineptine with those of amitriptyline and imipramine in anaesthetized rats.
    Balcioglu A; Bozkurt A; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1991; 309():64-74. PubMed ID: 1888231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular side effects of tricyclic antidepressants - a risk in the use of these drugs.
    Biamino G; Fenner H; Schüren KP; Neye J; Ramdohr B; Lohmann RW
    Int J Clin Pharmacol Biopharm; 1975 Apr; 11(3):253-61. PubMed ID: 1150371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of 5-hydroxytryptamine and tricyclic antidepressants in the rat stomach strip and the guinea-pig ileum.
    Akah PA; Tayo FM
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):201-9. PubMed ID: 4026457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the circulatory side-effects of 2-[3'-diethylaminopropyl-(1')-carbamoyl]-6,7-dimethoxy-1-thiaiso-chroman-1,1-di oxide ("16-252") (author's transl)].
    Rostock A; Poppe H; Nowak R; Femmer K
    Pharmazie; 1981 Apr; 36(4):287-90. PubMed ID: 7255531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
    Kushiku K; Morishita H; Furukawa T; Kitagawa H; Ueno K; Kitagawa H; Kohei H
    Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of desipramine and ciclazindol with adrenergic mechanisms in the human iris [proceedings].
    Kerr FA; Szabadi E
    Br J Clin Pharmacol; 1979 Oct; 8(4):396P-397P. PubMed ID: 508534
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the effects of chronic administration of ciclazindol and desipramine on pupillary responses to tyramine, methoxamine and pilocarpine in healthy volunteers.
    Kerr FA; Szabadi E
    Br J Clin Pharmacol; 1985 May; 19(5):639-47. PubMed ID: 4005103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration.
    Crews FT; Smith CB
    J Pharmacol Exp Ther; 1980 Oct; 215(1):143-9. PubMed ID: 6256516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic mechanisms in diet-induced thermogenesis: modification by ciclazindol and anorectic drugs.
    Rothwell NJ; Stock MJ; Wyllie MG
    Br J Pharmacol; 1981 Nov; 74(3):539-46. PubMed ID: 6271318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postsynaptic attack of tricyclic antidepressive agents in the circulatory system].
    Bobkiewicz T; Chodera A; Szpunar K; Drutel B
    Acta Biol Med Ger; 1975; 34?710():1675-9. PubMed ID: 1233850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ciclazindol on monoamine uptake and CNS function in normal subjects.
    Oh VM; Ehsanullah RS; Leighton M; Kirby MJ
    Psychopharmacology (Berl); 1979 Jan; 60(2):177-81. PubMed ID: 106428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors.
    Nojimoto FD; Mueller A; Hebeler-Barbosa F; Akinaga J; Lima V; Kiguti LR; Pupo AS
    Neuropharmacology; 2010; 59(1-2):49-57. PubMed ID: 20363235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Effect of tricyclic antidepressive agents and of Nomifensin (Hoe984) on the contractile properties of the isolated papillary muscle and on the tonus of the smooth vascular muscles].
    Biamino G; Nöring J; Neye G; Neye J
    Z Kardiol; 1975; Suppl 2():90. PubMed ID: 1242841
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of tricyclic antidepressants and barbiturates in barbiturate-tolerant and nontolerant rats.
    Liu SJ; Huang CL; Waters IW
    J Pharmacol Exp Ther; 1975 Aug; 194(2):285-95. PubMed ID: 1151759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.